dr.el gum care tooth- precipitated calcium carbonate, dibasic calcium phosphate, aluminium chlorohydroxy allantoinate, aminocapr
dr. el co., ltd. - calcium phosphate, dibasic, anhydrous (unii: l11k75p92j) (calcium cation - unii:2m83c4r6zb), calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb), alcloxa (unii: 18b8o9dqa2) (alcloxa - unii:18b8o9dqa2), aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - for dental care adults and children 2 years of age and older: brush teeth thoroughly, preferably after each meal or at least twice a day, or as directed by a dentist or physician children 2 to 6 years: use only a pea sized amount and supervise child's brushing and rinsing (to minimize swallowing) children under 2 years: ask a dentist or physician
dr.el berrygood tooth- silica, sodiuoroum monoflphosphate, tocopheryl acetate, hydrated silica paste, dentifrice
dr. el co., ltd. - hydrated silica (unii: y6o7t4g8p9) (hydrated silica - unii:y6o7t4g8p9), .alpha.-tocopherol acetate (unii: 9e8x80d2l0) (.alpha.-tocopherol - unii:h4n855pnz1), silicon dioxide (unii: etj7z6xbu4) (silicon dioxide - unii:etj7z6xbu4), sodium monofluorophosphate (unii: c810jcz56q) (fluoride ion - unii:q80vpu408o) - for dental care supervise children as necessary until capable of using without supervision. adults and children 6 years of age and older: bursh teeth thoroughly, preferably after each meal or at least twice a day, or as directed by a dentist or physician children 2 to 6 years: use only a pea sized amount and supervise child’s brushing and rinsing (to minimize swallpwing) children under 2 years: ask a dentist or physician
dr. hess hand sanitizer- alcohol gel
dr. hess wellness corp. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - antibacterial for rinse-free hand sanitizing to remove 99.9% bacteria on skin.
dr. easy instant hand sanitizing wipes- alcohol cloth
dr. easy bio-tech (hefei) co., ltd. - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - for sanitizing hands to decrease bacteria on the skin.
dr. easy hand sanitizing wipes- benzalkonium chloride cloth
dr. easy bio-tech (hefei) co., ltd. - benzalkonium chloride (unii: f5um2km3w7) (benzalkonium - unii:7n6jud5x6y) - hand sanitizer to help reduce bacteria on the skin.
dr. brandt sun shield spf 50- zinc oxide liquid
dr. brandt - zinc oxide (unii: soi2loh54z) (zinc cation - unii:13s1s8sf37) - sunscreen - helps prevent sunburn - if used as directed with other sun protection measures, (see directions) decreases the risk of skin cancer and early skin aging caused by the sun.
daptomycin dr.reddy's daptomycin 500 mg powder for injection vial
dr reddys laboratories australia pty ltd - daptomycin, quantity: 500 mg - injection, powder for - excipient ingredients: sodium hydroxide - daptomycin is active against gram positive bacteria only. in mixed infections where gram negative and/or certain types of anaerobic bacteria are suspected, daptomycin should be co-administered with appropriate antibacterial agent(s).,consideration should be given to official guidance on the appropriate use of antibacterial agents.,daptomycin is not indicated for the treatment of pneumonia.,adult patients (?18 years of age) complicated skin and skin structure infections,daptomycin is indicated for the treatment of adults (? 18 years of age) with complicated skin and skin structure infections (csssi) who require parenteral therapy and who have intolerance to alternative agents (especially penicillin allergy) or who have failed on other therapy, and when caused by organisms known to be susceptible to daptomycin.,staphylococcus aureus bloodstream infections (bacteraemia),daptomycin is indicated in adults (?18 years of age) for staphylococcus aureus bloodstream infections (bacteraemia), including right-sided native valve infective endocarditis (rie), caused by methicillin-susceptible and methicillin-resistant isolates.,the efficacy of daptomycin in patients with prosthetic heart valves or in left-sided endocarditis due to staphylococcus aureus has not been demonstrated. in the setting of staphylococcus aureus bacteraemia (sab), if a focus of infection is diagnosed as left-sided endocarditis after daptomycin therapy has been initiated, then consideration should be given to instituting alternative antibacterial therapy (see section 4.4 special warnings and precautions for use).,paediatric patients (1 to 17 years of age),daptomycin is not indicated for treatment of patients less than 1 year of age (see section 4.4 special warnings and precautions for use, paediatric use).,daptomycin has not been studied in treatment of infective endocarditis in children (see section 5.1 pharmacodynamic properties, clinical trials and section 4.4 special warnings and precautions for use).,complicated skin and skin structure infections,daptomycin is indicated for the treatment of patients aged 1 to 17 years with complicated skin and skin structure infections (csssi) who require parenteral therapy and who have intolerance to alternative agents (especially penicillin allergy) or who have failed on other therapy, and when caused by organisms known to be susceptible to daptomycin.,staphylococcus aureus bloodstream infections (bacteraemia),daptomycin is indicated in paediatric patients (1 to 17 years of age) with staphylococcus aureus bacteraemia not due to pneumonia, caused by daptomycin-susceptible isolates. empiric treatment should be reviewed based on the results of susceptibility testing. prescribing should be in accordance with nationally or locally-endorsed guidelines for the treatment of staphylococcus aureus bacteraemia.
daptomycin dr.reddy's daptomycin 350 mg powder for injection vial
dr reddys laboratories australia pty ltd - daptomycin, quantity: 350 mg - injection, powder for - excipient ingredients: sodium hydroxide - daptomycin is active against gram positive bacteria only. in mixed infections where gram negative and/or certain types of anaerobic bacteria are suspected, daptomycin should be co-administered with appropriate antibacterial agent(s).,consideration should be given to official guidance on the appropriate use of antibacterial agents.,daptomycin is not indicated for the treatment of pneumonia.,adult patients (?18 years of age) complicated skin and skin structure infections,daptomycin is indicated for the treatment of adults (? 18 years of age) with complicated skin and skin structure infections (csssi) who require parenteral therapy and who have intolerance to alternative agents (especially penicillin allergy) or who have failed on other therapy, and when caused by organisms known to be susceptible to daptomycin.,staphylococcus aureus bloodstream infections (bacteraemia),daptomycin is indicated in adults (?18 years of age) for staphylococcus aureus bloodstream infections (bacteraemia), including right-sided native valve infective endocarditis (rie), caused by methicillin-susceptible and methicillin-resistant isolates.,the efficacy of daptomycin in patients with prosthetic heart valves or in left-sided endocarditis due to staphylococcus aureus has not been demonstrated. in the setting of staphylococcus aureus bacteraemia (sab), if a focus of infection is diagnosed as left-sided endocarditis after daptomycin therapy has been initiated, then consideration should be given to instituting alternative antibacterial therapy (see section 4.4 special warnings and precautions for use).,paediatric patients (1 to 17 years of age),daptomycin is not indicated for treatment of patients less than 1 year of age (see section 4.4 special warnings and precautions for use, paediatric use).,daptomycin has not been studied in treatment of infective endocarditis in children (see section 5.1 pharmacodynamic properties, clinical trials and section 4.4 special warnings and precautions for use).,complicated skin and skin structure infections,daptomycin is indicated for the treatment of patients aged 1 to 17 years with complicated skin and skin structure infections (csssi) who require parenteral therapy and who have intolerance to alternative agents (especially penicillin allergy) or who have failed on other therapy, and when caused by organisms known to be susceptible to daptomycin.,staphylococcus aureus bloodstream infections (bacteraemia),daptomycin is indicated in paediatric patients (1 to 17 years of age) with staphylococcus aureus bacteraemia not due to pneumonia, caused by daptomycin-susceptible isolates. empiric treatment should be reviewed based on the results of susceptibility testing. prescribing should be in accordance with nationally or locally-endorsed guidelines for the treatment of staphylococcus aureus bacteraemia.
dr.noah maruftoothpaste- sodium monofluorophosphate paste
dr.noah - sodium monofluorophosphate (unii: c810jcz56q) (fluoride ion - unii:q80vpu408o) - ■ keeps teeth white and strong ■ keep the oral cavity clean ■ prevents tooth decay and bad breath caused by fluoride ■ removing plaque, preventing gingivitis and periodontitis ■ periodontal disease prevention ■ gum disease prevention for oral use only
dr.noah marutoothpaste- precipitated calcium carbonate paste
dr.noah - calcium carbonate (unii: h0g9379fgk) (calcium cation - unii:2m83c4r6zb) - ■ keeps teeth white and strong ■ keep the oral cavity clean ■ prevents tooth decay and bad breath caused by fluoride ■ removing plaque, preventing gingivitis and periodontitis ■ periodontal disease prevention ■ gum disease prevention for oral use only